Updates
August 20, 2026
K.C. Pharmaceuticals Eye Drop Recall – Case Investigation
The Block Firm is beginning to investigate the K.C. Pharmaceuticals eye drop recall and potential claims for those who have been affected. The FDA has…
August 19, 2026
Case Update: Butler v. Glenmark Pharmaceuticals Inc., USA
FDA Issues New Warning Letter Over Continued Manufacturing Failures The FDA has again flagged Glenmark Pharmaceuticals for serious manufacturing violations tied to its extended-release potassium…
August 17, 2026
AppleCare Class Action Update
The Block Firm continues to pursue its class action against Apple due to the company’s failure to cancel and refund AppleCare charges after consumers traded…
June 22, 2026
Strides Testosterone Gel Class Action Settlement
The Block Firm’s class action lawsuit, Painter, et al. v. Strides Pharma, Inc., has reached a preliminary settlement in the U.S. District Court for the…
October 24, 2025
Final Approval Granted in Breckenridge Class Action Settlement
The Block Firm is pleased to share that the U.S. District Court for the District of New Jersey has granted final approval of the nationwide class…
August 6, 2025
Federal Court Denies Apple’s Motion to Dismiss in The Block Firm’s AppleCare Class Action
In a significant development in our firm’s lawsuit against Apple over its handling of AppleCare+ charges, a federal judge in the Northern District of California…
July 28, 2025
FDA Issues Warning Letter to Glenmark Pharmaceuticals – July 11, 2025
On July 11, 2025, the U.S. Food and Drug Administration (FDA) issued a new warning letter to Glenmark Pharmaceuticals Limited. This letter outlines continuing significant…
May 28, 2025
The Block Firm Secures Preliminary Approval in Pharmaceutical Class Action Settlement
We are pleased to announce that the United States District Court for the District of New Jersey has granted preliminary approval of the proposed class…
May 22, 2025
The Block Firm Files Class Action Against Strides Pharma Over Benzene-Contaminated Testosterone Gel
The Block Firm has filed a class action lawsuit against Strides Pharma, alleging that the company distributed testosterone gel products contaminated with benzene, a known…
May 5, 2025
Did You See a Hair-Loss Ad from Hims? You Might Not Have Been Told the Whole Story.
Telehealth companies like Hims are spending millions on slick social media ads promoting topical finasteride—a spray version of a popular hair-loss drug. But here’s what…
OUR PEOPLE
We’re here when you need us.
